Lipella Pharmaceuticals | 10-Q: Q3 2024 Earnings Report
Lipella Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Michele Gruber(3.9%)
Lipella Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Leaf Huang(5.7%)
Lipella Pharmaceuticals | DEF 14A: Definitive information statements
Lipella Pharmaceuticals | 8-K: Current report
Lipella Pharmaceuticals | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Lipella Pharmaceuticals | 8-K: Current report
Lipella Pharmaceuticals | 8-K: Current report
Lipella Pharmaceuticals | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Michael B. Chancellor(16.0%)
Lipella Pharmaceuticals | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Jonathan H. Kaufman(16.2%)
Lipella Pharmaceuticals | 8-K: Current report
Lipella Pharmaceuticals | 8-K: Current report
Lipella Pharmaceuticals | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Michael B. Chancellor(18.8%)
Lipella Pharmaceuticals | D: Filing D
Lipella Pharmaceuticals | 10-Q: Q2 2024 Earnings Report
Lipella Pharmaceuticals | ARS: Annual Report to Security Holders
Lipella Pharmaceuticals | DEF 14A: Definitive information statements
Lipella Pharmaceuticals | 8-K: Current report
Lipella Pharmaceuticals | 8-K: Current report
Lipella Pharmaceuticals | 424B5: Prospectus
No Data
No Data